Atria Investments Inc Decreases Holdings in Aflac Incorporated (NYSE:AFL)

Atria Investments Inc trimmed its holdings in shares of Aflac Incorporated (NYSE:AFL) by 7.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 32,648 shares of the financial services provider’s stock after selling 2,525 shares during the quarter. Atria Investments Inc’s holdings in Aflac were worth $3,377,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in AFL. Pettinga Financial Advisors LLC purchased a new stake in shares of Aflac during the 3rd quarter valued at about $203,000. Principal Financial Group Inc. raised its position in shares of Aflac by 0.5% during the 3rd quarter. Principal Financial Group Inc. now owns 643,686 shares of the financial services provider’s stock valued at $71,964,000 after buying an additional 3,244 shares in the last quarter. Kornitzer Capital Management Inc. KS purchased a new stake in shares of Aflac during the 3rd quarter valued at about $246,000. AEGON ASSET MANAGEMENT UK Plc grew its holdings in Aflac by 0.9% during the 3rd quarter. AEGON ASSET MANAGEMENT UK Plc now owns 222,962 shares of the financial services provider’s stock valued at $24,925,000 after purchasing an additional 1,941 shares during the last quarter. Finally, CWA Asset Management Group LLC bought a new position in Aflac during the 3rd quarter valued at about $810,000. 67.44% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

AFL has been the topic of several analyst reports. BMO Capital Markets initiated coverage on shares of Aflac in a report on Thursday, January 23rd. They set a “market perform” rating and a $111.00 price target on the stock. Evercore ISI cut their price target on shares of Aflac from $104.00 to $102.00 and set an “underperform” rating on the stock in a report on Wednesday, December 4th. JPMorgan Chase & Co. upped their price target on shares of Aflac from $90.00 to $94.00 and gave the company a “neutral” rating in a report on Tuesday, January 7th. Wells Fargo & Company cut their price target on shares of Aflac from $104.00 to $102.00 and set an “equal weight” rating on the stock in a report on Wednesday, February 19th. Finally, Piper Sandler cut their price target on shares of Aflac from $122.00 to $118.00 and set an “overweight” rating on the stock in a report on Friday, February 7th. Two analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, Aflac currently has a consensus rating of “Hold” and a consensus price target of $103.36.

Insider Activity at Aflac

In related news, EVP Audrey B. Tillman sold 24,744 shares of Aflac stock in a transaction that occurred on Friday, December 27th. The shares were sold at an average price of $103.40, for a total transaction of $2,558,529.60. Following the transaction, the executive vice president now directly owns 222,618 shares of the company’s stock, valued at $23,018,701.20. This trade represents a 10.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. 0.90% of the stock is currently owned by corporate insiders.

Aflac Stock Performance

Shares of AFL stock opened at $108.48 on Friday. The firm has a market cap of $59.29 billion, a price-to-earnings ratio of 11.30, a PEG ratio of 3.24 and a beta of 0.93. The company’s 50 day moving average is $105.08 and its 200 day moving average is $107.72. The company has a quick ratio of 0.08, a current ratio of 0.10 and a debt-to-equity ratio of 0.29. Aflac Incorporated has a 52-week low of $79.31 and a 52-week high of $115.50.

Aflac (NYSE:AFL) last issued its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. On average, sell-side analysts anticipate that Aflac Incorporated will post 6.88 EPS for the current fiscal year.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.